Strengthening Cost Competitiveness by Leveraging Vietnam Production Facilities
First written in FY2016. 2 of 3 entries say "Restated". Latest entry: FY2025.
4 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「The Group is promoting risk diversification by increasing production and shipment volumes at Medikit Vietnam Co., Ltd.; utilizing the production building at the Hyuga Plant, located in a coastal area and also serving as a tsunami evacuation building; expanding the Hyuga No. 2 Plant, located inland; adding sterilization facilities and a distribution warehouse at the Hyuga No. 3 Plant; and maintaining product inventories at the Sakura Distribution Warehouse, which primarily covers eastern Japan.」
The company continues to describe its overseas production policy, including the use of its Vietnam production base, as part of a distributed operating structure with its domestic bases. - FY2018RestatedAnnual report
「In manufacturing, we will promote stronger cost competitiveness through the active utilization of our Vietnam production base.」
The company continues to position its Vietnam production base as a means of strengthening cost competitiveness. - FY2016First statedAnnual report
「In manufacturing, we will promote stronger cost competitiveness through the active utilization of our Vietnam production base.」
The company positions its Vietnam base not only as a means of expanding overseas but also as a means of enhancing cost competitiveness.